Pharmaceutical

NanoImaging Services Acquires Proteos, Enhancing Integrated Protein Sciences and Structure-Based Discovery Capabilities

SAN DIEGO, Jan. 6, 2025 /PRNewswire/ -- NanoImaging Services ("NIS"), the leading provider of cryo-electron microscopy ("cryo-EM") services for drug discovery…

12 months ago

Lumicell Announces Accomplished Healthcare Leader as New Member to Board of Directors

Independent director, Jim Alecxih, Chief Executive Officer of DH Medical joins Lumicell's Board of Directors NEWTON, Mass., Jan. 6, 2025…

12 months ago

Why Diversity in Clinical Trials Is So Important

NORTHAMPTON, MA / ACCESSWIRE / January 6, 2025 / Clinical trials are essential for the development of health care products,…

12 months ago

LivaNova Appoints Natalia Kozmina as Chief Human Resources Officer

LONDON--(BUSINESS WIRE)--#cardiacsurgery--LivaNova PLC (Nasdaq: LIVN), a market-leading medical technology company, today announced that Natalia Kozmina is joining the Company as…

12 months ago

Aytu BioPharma to Participate in the Lytham Partners 2025 Investor Healthcare Summit on January 13, 2025

DENVER, CO / ACCESSWIRE / January 6, 2025 / Aytu BioPharma, Inc. (the "Company" or "Aytu") (Nasdaq:AYTU), a pharmaceutical company…

12 months ago

Frontage Announces Co-CEO Promotions

EXTON, PA / ACCESSWIRE / January 6, 2025 / Frontage Holdings Corporation today announced that Dr. Abdul Mutlib has decided…

12 months ago

CASI Announces First Patient Dosed in Phase 1/2 Clinical Trial of CID-103 in Immune Thrombocytopenia

BEIJING, CHINA / ACCESSWIRE / January 6, 2025 / CASI Pharmaceuticals, Inc. (Nasdaq:CASI), a biopharmaceutical company specializing in the development…

12 months ago

AEON Biopharma, Inc. Announces Pricing of Approximately $20.0 Million Underwritten Public Offering

IRVINE, Calif., Jan. 06, 2025 (GLOBE NEWSWIRE) -- AEON Biopharma, Inc. (NYSE: AEON) (the “Company”), a clinical-stage biopharmaceutical company focused…

12 months ago

Achieve Life Sciences to Host Meetings During the J.P. Morgan Healthcare Conference Week

SEATTLE and VANCOUVER, British Columbia, Jan. 06, 2025 (GLOBE NEWSWIRE) -- Achieve Life Sciences, Inc. (Nasdaq: ACHV), a late-stage pharmaceutical…

12 months ago

Quoin Pharmaceuticals Announces Additional Positive Interim Data from Ongoing Open-Label Netherton Syndrome Clinical Study

Highly Positive Clinical Data on Completion of Testing for First Subject Dosed Twice Daily with QRX003 in Open-Label StudyDemonstrated Clinical…

12 months ago